𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gait Changes with Anti-Dementia Drugs: A Prospective, Open-Label Study Combining Single and Dual Task Assessments in Patients with Alzheimer’s Disease

✍ Scribed by O. Beauchet; C. P. Launay; G. Allali; F. R. Herrmann; C. Annweiler

Book ID
124072130
Publisher
Springer International Publishing AG
Year
2014
Tongue
English
Weight
389 KB
Volume
31
Category
Article
ISSN
1170-229X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and tolerability of rivastigmine
Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32)
✍ Jason T. Olin; Vinod Bhatnagar; Patricio Reyes; Barbara Koumaras; Xiangyi Meng; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

## Abstract ## Objective Rivastigmine, a dual cholinesterase inhibitor (ChEI), is widely approved for the symptomatic treatment of both mild‐to‐moderate Alzheimer's disease (AD) and Parkinson's disease dementia. Orally administered ChEIs may be associated with gastrointestinal (GI) side effects an